For how these effects fit into the receptor biology, discovery, and pipeline behind the class, see the wider view of GLP-1 and metabolic disease
The figures below come from separate trials in different populations, so cross-trial comparisons should be interpreted with caution
A Mounjaro has effects that inhibit gastrointestinal activity, so while it suppresses appetite, gastrointestinal symptoms such as anorexia, nausea, and burping may occur
In addition, investigators could titrate insulin glargine based on their discretion between study visits
Notice whether symptoms ease after rehydrating
Absorption is reliable and dosing is precise